lkp research shares & securities ltd initia ting coverage s ranganathan wockhardt limited rs 481 initiating buy industry pharmaceuticals reuters bloomberg codes wckh bo wpl in company p e 19x 52 week h l 522 rs325 market cap 17bn daily traded volume wk 57 650 key issues we are on based changing domestic product mix pioneering success biotechnology and ability to leverage its competitive positioning exports spent 7 of revenues r&d during cy 00 after having tasted with two recombinant products namely biovac b epox the plans introduce human insulin developed house through technology by 03 believe that is exploring alliances mnc abroad for marketing bio globally has about 200 scientists working peptide synthesis injectible depot systems chemistry novel drug delivery discovery comprising nearly 100 been focussing sepsis anti infectives nce molecules these areas currently undergoing late pre clinical studies wherein ind filings targeted
